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ABSTRACT 
Intracytoplasmic sperm injection (ICSI) allows the treat- 
ment of virtually every type of male infertility. Unlike in 
vitro fertilization (IVF), its success does not depend on 
sperm concentration, motility or morphology and most of 
the physical barriers to fertilisation are by-passed. Since 
ICSl does not require strongly motile sperm, its use has 
now been expanded to incorporate immature sperm from 
the testes and epididymides. Successful fertilisation, pre- 
gnancies and healthy babies have all been reported. 
However, concerns about the safety of ICSl remain due to 
its short clinical history and the lack of testing on animal 
models. 
Male fertility potential for assisted reproduction by ICSl 
cannot be measured by conventional parameters. Sperm 
DNA integrity is increasingly recognised as a more useful 
indicator. Studies have shown that sperm with higher 
levels of DNA damage have lower fertilisation rates after 
IVF and ICSI. Sperm with DNA damage above a certain 
threshold are associated with a longer time to conceive in 
otherwise apparently fertile couples and a higher miscar- 
riage rate. DNA damage has been shown to be associated 
with impaired embryo cleavage. Our group has shown 
that sperm DNA from testicular sperm is less fragmented 
than that from epididymal sperm and suggest its prefer- 
red use in ICSI. 
In addition to nuclear (n) DNA we also assessed the qua- 
lity of mitochondrial (mt) DNA from testicular sperm from 
men with obstructive azoospermia undergoing ICSI. We 
observed that couples achieving a pregnancy had both 
less mtDNA deletions and less nDNA fragmentation. We 
found inverse relationships between pregnancy and 
sperm mtDNA deletion numbers, size and nDNA fragmen- 
tation. No relationships were observed with fertilisation 
rates. With this knowledge, we designed an algorithm for 
the prediction of pregnancy based on the quality of sperm 
nDNA and mtDNA. 
Each year 40,000 men have a vasectomy in the UK but 
every year 2500 request a reversal to begin a second 
family. For such men, vasectomy reversal has recently 
been replaced in part by testicular biopsy via fine-needle 
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testicular sperm aspiration (TESA) or percutaneous epidi- 
dymal sperm aspiration (PESA) performed at an outpa- 
tient clinic and subsequently used in ICSI. Since these 
were previously fertile men it has been assumed that they 
had 'fertile' sperm. However the assisted conception suc- 
cess rates of these mens partners has not been assessed 
until recently. We have shown a significant reduction in 
the clinical pregnancy rates in the partners of men who 
had had a vasectomy >10yrs previously. There is also evi- 
dence to suggest that spermatogenesis is significantly 
impaired in vasectomised men. Marked decreases in 
spermatocytes, spermatids and spermatozoa have been 
observed. We have found this to be associated with 
concomitant increases in apoptotic markers, such as Fas, 
FasL and Bax. The quality of the remaining sperm is also 
compromised. Sperm DNA from vasectomized men 
shows substantial damage which increases with time 
after surgery. This new use of ICSI will be discussed. 
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Intracytoplasmic sperm injection (ICSI) is an invaluable 
innovation in the treatment of infertile couples, incorporating 
the use of testicular or epididymal sperm to provide treat- 
ment of infertile men with obstructive azoospermia [24, 36, 
77]. However, ICSI has removed many of the check points 
that prevent poor quality or immature sperm from fertilising 
oocytes. Motility, capacitation, the acrosome reaction and 
oocyte binding are no longer essential for fertilisation since 
the sperm is injected directly into the cytoplasm of the oocy- 
te. This has de-emphasised sperm selection by the criteria 
previously set for in vitro fertilization (IVF) and allowed the 
arbitrary choice of sperm for injection. For the first time in 
history, we have perfected a technique that circumvents all 
these natural barriers to fertilisation thus facilitating the 
union of potentially defective gametes. It is now generally 
accepted that male infertility can be passed from infertile 
fathers to sons born as a result of ICSI. As yet, the effects 
of ICSI on long term health of these children are unknown. 
Another ramification of the success of ICSI has been a ces- 
sation of research into sperm dysfunction as success rates 
do not appear to be influenced by previous World Health 
Organisation criteria. 
Intracytoplasmic sperm injection offers men with azoosper- 
mia their first opportunity to father their own genetic child- 
ren. Azoospermia is the most severe form of male infertility 
where sperm are absent from the ejaculate, due either to a 
genital tract obstruction (obstructive azoospermia) or sper- 
matogenic failure (non-obstructive azoospermia). Its inci- 
dence is 1% in the general male population increasing to 
10-15% of infertile men [85]. Forty-five to 75% of these men 
have obstructive azoospermia [57, 85] usually caused by 
congenital absence of vas deferens (CBAVD), post-infecti- 
ve epididymitis (from gonorrhoea, chlamydia or tuberculo- 
sis), and in rare cases by Young's syndrome or 
Kartagener's syndrome [90]. Obstructions can also be 
acquired by vasectomy or iatrogenic injuries. In men with 
obstructive azoospermia their testicular histology is normal. 
Endocrinological investigation usually shows normal follicle 
stimulating and luteinising hormone levels and a normal 
karyotype. This is in contrast to those men with non-obs- 
tructive azoospermia whose hormone levels are elevated 
and whose testes are often small with a soft consistency. 
Non obstructive azoospermia is associated with spermato- 
genic impairment. This may be manifested in maturation 
arrest or by a complete absence of sperm in the seminife- 
rous tubules, Sertoli cell only syndrome. 
II. THE MANAGEMENT OF MEN WITH 
OBSTRUCTIVE  AZOOSPERMIA  
Azoospermia is determined by two semen analyses where 
no sperm are observed. This is followed by an examination 
of the patient together with history, endocrine profile and 
karyotyping. Until recently it has been accepted that normal 
levels of FSH and LH are predictive of the presence of 
sperm in the seminiferous tubules [73]. Inhibin B has also 
be suggested as a useful predictor [7]. However more 
recent reports [22, 34, 50] have reported their poor predicti- 
ve value. The predictive value of testicular histology has 
more support with positive correlations with successful 
gamete retrieval in numerous studies [89, 78, 74, 79]. 
A diagnostic biopsy (see range of methods below) will be 
performed before the female partner begins her ovulation 
stimulation regime. Any histopathology in the biopsy will be 
determined and sperm will be frozen and thawed to deter- 
mine their susceptibility to cryo-injury. If suitable, a treat- 
ment biopsy will be performed, either on the day of ooctye 
retrieval if fresh sperm are to be used or prior to that day if 
frozen sperm are to be utilized. 
III. SPERM RETRIEVAL TECHNIQUES 
The first technique employed for sperm retrieval was micro- 
surgical epididymal sperm aspiration (MESA) by Temple- 
Smith et aL in 1985 [88]. 
This is an invasive procedure involving opening the scrotum 
to investigate epididymis and testes. As such it requires 
theatre time and a team of trained staff making it a deman- 
ding and expensive task. Although this was still an option a 
decade later when Devroey et aL, [23] reported their open 
testicular biopsy TESE technique, sperm retrieval was 
rapidly simplified to less invasive percutaneous epididymal 
sperm aspirations (PESA) by Craft et al., [17] or fine need- 
le testicular sperm aspirations (TESA) by Craft and 
Tsirigotis [18]. In these, sperm are retrieved under local 
anaesthetic in technically less demanding, less traumatic 
outpatient procedures. However, Tournaye et al. have 
reported [89] that the main limitation of these techniques 
was that the total number of sperm retrieved were signifi- 
cantly lower than from open biopsy. 
In our centre [83] we modified the TESA technique using a 
larger guage needle (14 guage) to allow an increased num- 
ber of sperm to be retrieved in an attempt to retrieve all the 
sperm required for male's future reproductive needs from 
one biopsy. 
IV. LONG TERM EFFECTS OF BIOPSIES 
Several studies examining gross testicular parameters fol- 
lowing biopsies have shown no damage. Our group [84] 
assessed the post biopsy status of the testis in terms of 
hematomas and scars by postbiopsy testicular ultrasound, 
serum antisperm antibodies and pituitary gonadotrophins 
and testosterone levels and found no significant differen- 
ces. Similarly, Schill et al., [72] found no alterations in endo- 
crine function or testicular size (assessed by Doppler scro- 
tal sonography). In contrast, Ramasamy et aL, [67] found a 
significant decrease in testosterone three to six months 
after TESE surgery with concomitant increases in follicle sti- 
mulating hormone and luteinizing hormones. Pathological 
consequences of biopsying have also been reported by 
Schlegel et aL [73] with a high incidence of both inflamma- 
tion and haematomas and also devascularization in a small 
number of patients. Animal studies have allowed more 
detailed investigations of the impact of repeated testicular 
aspirations. Even these less invasive 'fine needle' methods 
of sperm retrieval have been shown to cause 'severe, pro- 
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gressive and irreversible damage on the architecture of the 
tubules in the needle's path' [76]. This group also reported 
that the degree of damage increased with repeated proce- 
dures. They [76] also shown that TESE causes localized 
scarring and fibrosis. This may account for evidence that 
scarring from previous biopsies impairs the retrieval of 
sperm in subsequent attempts [63]. 
V. FOLLOW UP OF BABIES CONCEIVED BY ICSI 
Since the choice of a sperm for ICSI is arbitrary, in fact often 
using immature sperm which Nature would reject, there 
have been concerns as to the safety of ICSI and the health 
of children conceived in this way. Initial data [13] albeit 
conflicting [11], suggested that the mental development of 
ICSI babies was slower. The differences between these stu- 
dies may be due to insufficient numbers or confounding fac- 
tors such as differing socio-economic groups. Major and 
minor congenital anomalies [44] were also reported to be 
more prevalent in ICSI babies than in the general popula- 
tion. However, in a large comparative study in 2000 
Wennerholm et al., [101] compared ICSI births with IVF 
births and found no increase in major malformations bet- 
ween these two groups, concluding that this increased rate 
of congenital malformations is not associated with sperm 
origin or quality but rather due to a higher rate of multiple 
births. In 1998, the European Society Human Fertilization 
and Embryology ICSI Task Force confirmed the findings of 
smaller studies, reporting an increased risk (2%) of chromo- 
somal abnormalities in ICSI babies [87]. 
The next major study was conducted by the International 
collaborative study of ICSI child and family outcomes group 
over a five year period [87] and no differences in cognitive, 
neurological or socio-economic development were obser- 
ved although they highlighted an increase in urogenital pro- 
blems in males more recently. In 2004 a meta-analysis [68] 
found compared major malformations rates ranged from 
1.1-9.7% in ICSI compared with 0-6.9% in spontaneously 
conceived infants. However they stressed that some of the 
studies had inappropriate control groups, including infertile 
patients who had then conceived without treatment and 
suggested that this increased the rate of malformations in 
the controls. Most recently, a systematic review of all the 
papers with data relating to birth defects in infants following 
ICSI and or tVF compared with spontaneously conceived 
infants was published [35] where the results of the meta- 
analysis suggested a dramatic 30-40% increase of birth 
defects associated with ART. This latest paper has led to 
renewed interest and active debate. 
Vl. COMPARISON OF SUCCESS RATES FOR 
AZOOSPERMIA OF DIFFERING AETIOLOGIES 
The cause of a man's azoospermia has an influence on the 
couples' ICSI outcome. Again, meta-analyses have played 
a major role in drawing together our knowledge to date. 
Significantly higher fertilization rates and clinical pregnancy 
rates have been reported in men with obstructive azoosper- 
mia compared with those who presented with non obstruc- 
tive azoospermia [57]. These findings are supported by 
those from a large retrospective analysis of 911 ICSI cycles 
[96]. Several studies have reported this trend of lower suc- 
cess outcomes culminating with lower live birth rates and 
increased miscarriages [31, 94]. However, again the meta- 
analysis previously cited [57] concludes for those couples 
achieving a pregnancy there was no difference in ongoing 
pregnancy rates or miscarriage rates. Further, Vernaeve et 
al. [96] have reported non significant differences in multiple 
births, preterm deliveries and tow birth weights. 
VII. THE IMPORTANCE OF SPERM NUCLEAR 
AND MITOCHONDRIAL DNA ON ASSISTED 
REPRODUCTIVE OUTCOME 
Male fertility potential for assisted reproduction by ICSI can- 
not be measured by conventional parameters. Sperm 
nuclear DNA (nDNA) integrity is increasingly recognised as 
a useful indicator of male fertility potential. Sperm with 
nDNA damage above a certain threshold are associated 
with a longer time to conceive in otherwise apparently ferti- 
le couples [28, 80] and a higher miscarriage rate [28]. 
Infertile men have also been shown to have more nDNA 
anomalies than sperm donors and fertile men [70, 39, 102]. 
These defects include poor DNA packaging [70, 30] increa- 
sed strand breaks [49, 39] greater susceptibility to DNA 
denaturation [28] and a higher incidence of chromosomal 
abnormalities [54]. In ICSI cycles, DNA damage has been 
shown to be associated with impaired embryo cleavage 
[55]. In addition, higher rates of pregnancy loss have been 
documented in ICSI than in IVF [8]. As these pregnancies 
were almost inevitably achieved with sperm of poor quality 
that would have been incapable of fertilising an oocyte natu- 
rally, there may well be a link with sperm nDNA damage. 
Yet, because of the success of ICSI in bypassing rather 
than addressing the problem of poor sperm quality, such 
defective sperm are being used indiscriminately in clinical 
treatments. 
The nucleus is not the sperm's only source of DNA. The 
mitochondrion also has its own genome. During recent 
years, mtDNA mutations have been identified in numerous 
diseases [98]. Mitochondrial DNA changes have also been 
identified as the origin of ageing [75] and more recently as 
a cause of male infertility [19, 81]. Mitochondrial DNA is also 
an indicator of the health of the sperm. Mitochondrial DNA 
deletions lead to deficient OXPHOS that, in turn, causes 
abnormal metabolism and inadequate sperm motility. We 
recently studied the relationship between testicular sperm 
mitochondrial (mt) DNA deletions, nuclear (n) DNA frag- 
mentation from 28 men with obstructive azoospermia 
undergoing ICSI and their partners' fertilisation and pre- 
gnancy rates after ICSI. The testicular sperm were retrieved 
using a 14 guage Trucut needle. MtDNA analysed using a 
long polymerase chain reaction and an alkaline Comet 
assay was used to determine nDNA fragmentation. Of sub- 
jects who achieved a pregnancy (50%) using testicular 
sperm, only 26% had partners' sperm with wild type (WT) 
mtDNA. Further, the successful group had less mtDNA 
deletions and less nDNA fragmentation. There were inverse 
relationships between pregnancy and mtDNA deletion num- 
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bers, size and nDNA fragmentation for both testicular and 
ejaculated sperm (Table 1). No relationships were observed 
with fertilisation rates. We combined the data about DNA 
quality from both sources within sperm to provide a poten- 
tially valuable prognostic test. The information was incorpo- 
rated into a simple scoring system for clinicians to use to 
counsel patients more appropriately (Figure 1). For the first 
time, by using this algorithm the clinician will be able to give 
couples a more quantitative estimate of their chances of a 
pregnancy from their treatment. 
VIII. TEST ICULAR SPERM VULNERABIL IT IES  
TesUcular sperm DNA. Sperm chromatin differs from 
somatic cells in structure and composition. During spermio- 
genesis the majority of histones are replaced with small, 
highly basic protamines [64] that are half the size of histo- 
nes [29] and organized into unique supercoiled doughnuts, 
called toroids [99]. During transit through the epididymis, 
the protamines crosslink by forming disulphide bonds and 
this process compresses sperm DNA into one sixth the 
volume occupied by somatic cell nuclei [29]. This highly 
cross-linked structure affords a measure of protection to 
sperm DNA and to some extent compensates these cells for 
their impaired DNA repair capacity. Thus, testicular sperm, 
in which this process have not been completed, appear to 
be more susceptible to DNA damage than ejaculated sperm 
[47, 33, 5]. 
IX. CRYOIN JURY AND TEST ICULAR 
SPERM CULTURE 
Analysis of incubation effects on testicular sperm DNA is 
also extremely relevant since this is now routine clinical 
practice [48]. The selection of ejaculated sperm for ICSI 
involves the evaluation of motility, as this gives an indication 
of the viability of the sperm [58]. The selection of viable tes- 
ticular sperm for ICSI can be difficult due to lack of inherent 
motility and the choice of a nonviable sperm may lead to 
lower fertilisation rates than obtained with ejaculated sperm 
[26]. Cryopreservation of testicular sperm ensures the avai- 
lability of sperm for subsequent reatment cycles without the 
need to perform additional biopsies [77]. 
The technique of culturing testicular sperm in vitro prior to 
ICSI has been recommended by a number of groups [48, 6, 
37, 27] in order to promote an increase in sperm motility. A 
period of 24 hours has been suggested as optimal for the 
development of motility in a sufficient number of testicular 
sperm to give choice in the treatment cycle [37]. However, 
the process of freeze-thawing has been found to signifi- 
cantly decrease the vitality of testicular sperm immediately 
post-thaw [95]. Ultrastructural cryoinjuries have also been 
observed in thawed testicular sperm in the form of rupturing 
of the plasma and acrosomal membranes [59]. The use of 
simulated maturation of testicular sperm in vitro assumes 
that it has only positive effects. Very often culturing in vitro 
takes place in simple, unsupplemented media [48, 6, 37] or 
media which is not changed or gassed with CO2 for up to 7 
days [26]. This may lead to a lack of energy substrates for 
the sperm as they develop motility and also a change in pH 
in the culture media. 
Oxidative stress and ROS production have been shown to 
increase during incubation of ejaculated sperm and indeed 
to peak at 24 hours [15]. Sperm produce low levels of ROS 
naturally as by-products of the electron transfer chain, 
however, these may accumulate during culture and gra- 
dually become toxic to the sperm [2]. Testicular sperm are 
more susceptible as they produce more ROS, possessing 
residual cytoplasm prior to transit through the epididymis 
[32]. 
Retained cytoplasm in immature sperm has high levels of 
nicotinamide adenine dinucleotide phosphate (NADPH) oxi- 
dase [3], which acts as a substrate in the generation of 
superoxide (O2"-), which causes lipid peroxidation and DNA 
damage [92]. However, the amount of cytoplasm is not 
enough to afford them antioxidant protection [4]. Culture of 
Table 1 : Relationships between fragmented DNA in fresh, frozen-thawed and post-cryopreservation incubated testicu- 
lar sperm. From Lewis et al. [47]. 
nDNA mtDNA mtDNA 
Sperm ISCi/'I'ISC! 
n fragmentation deletion deletion 
Source Outcome 
(%) number size (kb) 
Testicular 14 Pregnant 16.1 +1.7 1.29+0.29 3.08+0.52 
Testicular 14 Not Pregnant 26.4+3.1" 2.86+0.35* 5.91 +_0.41" 
Ejaculated 26 Pregnant 21.4+2. I t  2.43+0.29 t 3.90-+0.30 t 
Ejaculated 41 Not Pregnant 27.4+-1.5" 3.29+-0.22* 4.69+-0.27* 
Values are means + S.E. 
* P<O.05 significant differences between successful and unsuccessful outcome with testicular or ejaculated sperm. 
t P<O.05 significant differences between testicular and ejaculated sperm. 
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Figure 1 : Graphical description of probability. From 
Lewis et al. [47]. A plot of prognostic score against pre- 
dicted probabilities from the regression model showing 
linearity over a broad range of probabilities. For example, 
a prognostic score of 84 gives a probability of pregnancy 
of 91%, a prognostic score of 47 gives a probability of 
pregnancy of 47% and a prognostic score of 3 gives a 
probability of pregnancy of only 5%. 
testicular sperm to facilitate motility acquisition [58] may 
lead to an accumulation of ROS, 02"- and hydrogen per- 
oxide (H202), which could overwhelm the sperm antioxi- 
dant defence. H202 is not intrinsically toxic to sperm but it 
inactivates a ROS scavenging system instead, making 
sperm susceptible to gradual oxidative DNA damage from 
ROS [42]. Additionally, the accumulation of ROS may be 
released into the culture medium, which contains no anti- 
oxidant protection, allowing further damage to sperm plas- 
ma membranes. 
Production of 02-- has also been found to increase during 
the cooling process for freezing sperm and to a greater 
extent in the freeze-thawing process in bovine ejaculated 
sperm [16]. In the same study it was noted that H202 did 
not significantly increase and suggested that the 02"- anion 
was not generating H202 but causing oxidative damage to 
cellular structures. This may provide a reason why the DNA 
damage observed in this study is greater immediately after 
thawing than in fresh sperm, and why incubation of testicu- 
lar sperm post-cryopreservation causes greater damage to 
the DNA (30.4%) than incubation of fresh testicular sperm 
(19.1%). ROS acting on DNA during the cooling period 
before freezing and during thawing may predispose the 
DNA to further damage during post-thaw incubation. The 
use of antioxidants upplements in media during incubation 
may reduce free radicals and oxidants [97]. 
Work from our laboratory [25] has shown that mature sperm 
DNAfrom infertile men is damaged by freeze-thawing, while 
in fertile men, the DNA is unaffected. In contrast, cryoinjury 
is observed similarly in testicular sperm from fertile and 
infertile men. This may be due to the fact that all testicular 
sperm are more vulnerable to oxidative damage than eja- 
culated sperm since their DNA is not yet crosslinked for pro- 
tection although having completed spermiogenesis, trans- 
cription and translation and therefore the ability to repair, is 
switched off [4]. 
Cryopreservation has been found to have a detrimental 
effect on the viability [66] and morphology of testicular and 
ejaculated sperm [95, 60] due to the formation of intracellu- 
lar ice, which causes the rupturing of plasma membranes 
[53]. Another group detected swelling and rupturing of the 
acrosomal and plasma membranes after freeze-thawing, 
also in testicular sperm [59]. These morphological altera- 
tions, which occur during cryopreservation, may lead to the 
increased vulnerability of testicular sperm demonstrated in 
this study, due to plasma membrane damage allowing ROS 
to access sperm nuclei and adversely affect DNA integrity 
during incubation. Testicular sperm morphology was found 
to be comparable between fertile and infertile men [82] 
without cryopreservation. This may also explain why testi- 
cular sperm DNA from fertile men are no better at withstan- 
ding the freezing process than those from obstructive 
azoospermic men. 
Incubation of fresh testicular sperm appears to be beneficial 
only in terms of motility and morphology development and 
in the selection of the best viable sperm for ICSI. However, 
incubation of fresh and frozen-thawed testicular sperm is 
clearly damaging to nuclear DNA (Table 2). Our study [20] 
provided compelling evidence that fresh and frozen-thawed 
testicular sperm should be injected without delay in order to 
protect the genetic health of the resulting child. As even 
sperm with damaged DNA can fertilise oocytes during ICSI 
[93], it is vital that steps be taken to protect the sperm DNA 
and consequently lower the risk of passing damaged gene- 
tic information to the offspring. 
X. POST VASECTOMY TESTICULAR SPERM 
YIELDS 
Each year 40,000 men in the UK have a vasectomy. 
Traditionally, vasectomy was considered an irreversible 
form of contraception. However, increasingly men are 
requesting reversal to have a second family and now 2400 
(~6%) men request reversal [65]. Even when surgery is suc- 
cessful, anti-sperm antibodies impair sperm function in up 
to 50% of cases thus reducing fertility, tn addition, Kolettis 
et al. [41] found that vasectomy reversal is associated with 
seminal oxidative stress which can impair sperm structure 
[38] and function [21]. There is evidence that men who have 
had a vasectomy for less than 2yrs have a 50% chance of 
a pregnancy whereas those whose male partners had their 
vasectomy more than 15yrs previously have a 30% chance 
of a spontaneous pregnancy [51]. Since these were pre- 
viously fertile men it has been assumed that they had 'ferti- 
le' sperm. However, as yet, the long term consequences of 
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Table 2 : Relationships between fragmented DNA in fresh, 
frozen-thawed and post-cryopreservation incubated testi- 
cular sperm. From Dalzell et aL [20]. 
Time point of DNA 
Group analysis fragmentation % P 
mean + S.E. 
Fresh 9.4 + 0.65 
Fertile 
Frozen-thawed 15.5 • 1.16 0.013 
n=18 
24 hr post-thaw 18.5 • 1.58 0.007 
Infertile 
n=34 
Fresh 10.6 + 1.02 
4 hr 22.1 • 3.49 0.052 
24 hr 19.1 + 2.33 0.017 
Frozen-thawed 16.5 • 1.00 0.0001 
4 hr post-thaw 29.5 +_ 1.45 0.00004 
24 hr post-thaw 30.4 • 1.71 <0.00001 a 
Note : P values are comparisons to fresh data in each group. 
a Difference between fertile and infertile groups, p = 0.00001. 
vasectomy on testicular, sperm function or future fertility 
have not been well documented. 
For men wishing to have second families post-vasectomy, 
vasectomy reversal, since 1995, has been replaced in part 
by testicular biopsy via fine-needle testicular sperm aspira- 
tion (TESA) or percutaneous epididymal sperm aspiration 
(PESA) performed at an outpatient clinic and subsequently. 
Sperm obtained can then be used in ICSI. 
We determined the effects of vasectomy on sperm yield and 
testicular histology. Secondly, we aimed to compare the fer- 
tility outcomes (cumulative embryo score and clinical pre- 
gnancy rates) after assisted conception of normal female 
partners of vasectomised men and men with obstructive 
azoopsermia (OA) [52]. 
Sperm yields/g of testis were significantly decreased in men 
vasectomised 5-9 yrs and ->10yrs previously and also in 
obstructive azoospermic men of other aetiologies, relative 
to fertile men (Table 3). A significant reduction was also obs- 
erved in the number of early (40%, p<0.005) and mature 
(29%, p<0.05) spermatids, and an increase of 31% was 
seen in the thickness of the seminiferous tubule wall (basal 
membrane and collagen) of vasectomised men >10yrs rela- 
tive to fertile men. There was a significant reduction in the 
clinical pregnancy rates in the partners of men who had had 
a vasectomy >10yrs previously (Table 3). 
XI .  POST-VASECTOMY PREGNANCY RATES 
We also assessed the clinical pregnancy rate of the part- 
ners of men who have undergone a vasectomy using TESA 
Table 3 : Effects of  vasectomy on sperm yield. From 
McVicar  et al. [52]. 
Group 1 Group 2 Group 3 Group 4 
Vas 5-9yrs Vas_>10yrs OA Fertile 
n=12 n=12 n=32 n=39 
Sperm 
y ie ld  3.61 + 3.79 + 3.00 + 11.18 + 
x 1061g 1.26 * 1.06 * 0 .43 * 1.56 
+ SEM 
* p=0.000 each compared with Group 4. 
followed by ICSI. We found a significant reduction (28 to 
9%) in the clinical pregnancy rate of the partners of the men 
who have had a vasectomy >-10yrs relative to those of men 
with OA from other aetiologies. Our work confirms that of 
Abdelmassih et al. [1] who have recently reported a negati- 
ve correlation between pregnancy rates after ICSI using 
epididymal sperm and an increasing time interval after 
vasectomy. This is also supported by Borges et al. [10, 12] 
who used sperm retrieved from the epididymis followed by 
ICSI after vasectomies 14yrs previously. They reported an 
increase in miscarriage rates. Further, Kubota [43] reported 
degenerative changes in the spermatids and sperm of 
vasectomised men. All these studies suggest that the quali- 
ty of post-vasectomy sperm may be compromised and that 
they are less capable of achieving a pregnancy. 
Xl l .  APOPTOSIS  AND POST-VASECTOMY SPERM 
YIELDS 
We sought to determine a mechanism by which this reduc- 
tion in sperm yield and pregnancy rate was effected by 
investigating the incidence of apoptosis in the seminiferous 
tubules (Figure 2) [62]. In general, apoptosis plays an 
important role in the testis [45, 69] by eliminating 50-70% of 
germ cells at different stages of spermatogenesis prior to 
spermiogenesis [40, 9, 61]. This results in the maintenance 
of the maximum number of cells that can be optimally sup- 
ported by the fixed population of Sertoli cells under the 
changing conditions of the testis as for example during 
stress or infection [71, 14]. The key initiator of testicular 
apoptosis is believed to be the Fas/FasL pathway [45, 46]. 
It is then regulated by many protein interactions, including 
those of the Bcl-2 family, before the cells commit to the pro- 
cess via caspases and later endonuclease activation. 
Caspase 3 is the main executor of this irreversible apopto- 
tic cascade [100]. 
We observed increased intensities of FasL and Bax staining 
in the seminiferous tubules in vasectomised men. FasL 
positivity (%) also increased in Sertoli cells, and both FasL 
and Fas positivity (%) increased in primary spermatocytes 
and round spermatids of vasectomised men. Sperm DNA 
fragmentation, an end point marker of apoptosis, increased 











5 10 15 20 25 
Years since Vasectomy 
Figure 2 : Correlation between DNA fragmentation and 
years since vasectomy. From O'Neill et al., 2006 [62] (pro- 
visional acceptance). 
We concluded that reduced sperm yields post-vasectomy 
were associated with increased apoptosis via the Fas-FasL 
and Bax pathways with the remaining sperm displaying 
increased DNA fragmentation. 
Xlll. POST-VASECTOMY TESTICULAR SPERM 
QUALITY 
The elevated sperm DNA damage increasing with time obs- 
erved by us (Figure 2) is supported by Steger eta/., [86] 
who reported a post-vasectomy alteration of sperm nuclear 
chromatin condensation as a result of delayed protamine 
expression. Histone-protamine xchange is known to play 
an important role in the protection of sperm DNA by com- 
paction and is essential for the maturation of healthy sperm. 
Steger's group also observed spermatogenic arrest at the 
round spermatid stage in association with delayed expres- 
sion of protamine transcripts. This DNA fragmentation may 
be an indication of the irreversible late stage execution of 
apoptosis. It also gives us a possible explanation of the 
reduction in the clinical pregnancy rate in the partners of the 
vasectomized men recently reported by us [52]. Our work is 
in agreement with Abdelmassih eta/.  [1], who recently 
reported a negative correlation between pregnancy rates 
after ICSI using epididymal sperm and an increasing time 
interval after vasectomy although in conflict with 
Nicopoullos eta/., [56] who found that maternal age, and 
not the interval since vasectomy was the principal determi- 
nant of ICSI success. Also in support is a study by Borges 
eta/. [10] who used sperm retrieved from the epididymis fol- 
lowed by ICSI after vasectomies 14yrs previously. In addi- 
tion, they reported an increase in miscarriage rates. All 
these studies suggest that the quality as well the quantity of 
post-vasectomy sperm may be compromised and that they 
are less capable of achieving a pregnancy. Men seeking 
vasectomies and infertility specialists should be made 
aware of these long term effects and their implications for 
future infertility treatment for this group of patients. 
XIV. CONCLUSION 
Treatments for azoospermic men have been advanced 
enormously by the introduction of ICSl and its facility to 
use immature sperm. Assisted conception success 
rates are now as high using these sperm as with ejacu- 
lated sperm. However, there appears to be a hesitance 
to apply our ever expanding knowledge of testicular 
sperm characteristics to best cl inical practice. If, in the 
future, clinicians and scientists work more closely, 
there wil l  be the opportunity to improve success rates 
and benefit more patients in this exciting area of andro- 
Iogy. 
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RESUME 
Traitement de I'azoospermie obstructive par injection 
Intracytoplasmique d'un spermatozo'~'de 
Sheena E.M. LEWIS 
L'injection intracytoplasmique d'un spermatozo'ide (ICSI) 
permet de traiter virtuellement n'importe quel type d'inf(~- 
conditd masculine. A la diffdrence de la F6condation in 
vitro (FIV), son succ~s ne d(~pend pas de la concentration, 
de la mobilitd ou de la morphologie des spermatozoYdes et 
la plupart des barri~res physiques b la f~condation sont 
ainsi contourn6es. Puisque I'ICSI ne requiert pas de sper- 
matozo'l'des fortement mobiles, son usage a dt(~ mainte- 
nant (Hargi b I'utilisaUon des spermatozo'ides immatures 
des testicules et des 6pididymes. Une f6condation r~us- 
sie, des grossesses, et des enfants en bonne sant(~ ont 
tous 6t6 rapport~s. Toutefois, persistent des inqui~tudes b 
propos de I'innocuitd de I'ICSl qui sont dues b sa br~ve 
existence clinique et b I'absence d'expdrimentation sur 
des mod61es animaux. 
Le potentiel de fdcondit~ masculine pour la reproduction 
assist6e par ICSl ne peut pas 6tre mesurd par les param~- 
tres convenUonnels. L'intdgrit6 de I'ADN spermatique est, 
de fagon grandissante, reconnue comme un indicateur 
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plus utile. Des dtudes ont montr(~ que les spermatozo'ides 
ayant des taux 61evds d'alt6ration de I'ADN, ont des taux 
de fdcondation plus faibles en FIV et en ICSI. Les sperma- 
tozo'ides avec une alt(~ration de I'ADN au-dessus d'un cer- 
tain seuil sont associ(~s & une augmentation du ddlai pour 
concevoir chez des couples par ail leurs apparemment 
f(~conds, et & un taux 61ev(~ de fausses-couches. On a mon- 
tr~ que I'alt(~ration de I'ADN ~tait li(~e ~ une segmentation 
embryonnaire d(~fectueuse. Notre groupe a rapport& que 
I'ADN de spermatozo'ides provenant du testicule 6tait 
moins fragment(~ que I'ADN de spermatozo'ides provenant 
de I'(~pididyme, ce qui sugg/)re I'util isation pr(~fdr(~e des 
premiers en ICSl. 
En plus de I'ADN nucldaire (n), nous avons aussi (~valu(~ la 
qualitd de I'ADN mitochondrial (mt) dans les spermatozo'i- 
des testiculaires d'hommes avec azoospermie obstructive 
en cours d'ICSl. 
Nous avons observd que les couples qui obtenaient une 
grossesse, avaient 8 la fois moins de ddl6tions de I'ADNmt 
et moins de fragmentation de I'ADNn. Nous avons trouv(~ 
une relation inverse entre grossesse d'une part, et d'autre 
part, nombres de d61(~tion de I'ADNmt et tail le et fragmen- 
tation de I'ADNn des spermatozo'ides. Aucune relation n'a 
dt6 observ(~e avec les taux de f(~condation. Avec ces don- 
n(~es, nous avons 6tabli un algorithme pour la pr6diction 
de grossesses, bas6 sur la qualit(~ de I'ADN, et I'ADNmt 
des spermatozo'ides. 
Chaque ann6e 40 000 hommes ont une vasectomie au 
Royaume Uni, mais chaque ann(~e 2500 demandent une 
reperm(~abilisation pour fonder une seconde famille. Pour 
de tels hommes, la r(~version de la vasectomie a r6cem- 
ment dt(~ remplac6e en partie par la biopsie testiculaire, au 
moyen de I'aspiration de spermatozo'ides testiculaires 
I'aiguille fine (TESA) ou de I'aspiration percutan(~e de sper- 
matozo'ides (~pididymaires (PESA), r(~alis6e n ambulatoire 
et utilis6e ensuite en ICSl. Puisque ces hommes (~taient 
auparavant des hommes f(~conds, on les a consid6r6s 
comme ayant des spermatozo'ides "f(~conds". Toutefois, 
les taux de succ(~s en conception assist(~e des partenaires 
de ces hommes n'ont 6t(~ 6valuds que r(~cemment. Nous 
avons montr6 une r(~duction significaUve des taux de 
grossesse clinique chez les partenaires des hommes qui 
avaient eu une vasectomie plus de 10 ans auparavant. II 
existe aussi des (H&ments qui sugg6rent que la spermato- 
gen~se est alt(~rde de fa(;on significaUve chez les hommes 
vasectomisds. Une diminution importante des spermato- 
cytes, des spermatides et des spermatozo'ides a ~t(~ obs- 
erv6e. Nous avons trouv(~ que celle-ci (~tait associ(~e a une 
augmentation concomitante des marqueurs de I'apoptose, 
comme le Fas, FasL et Bax. La qualit(~ des spermatozo'ides 
qui restent est aussi compromise. L'ADN des spermato- 
zo'ides d'hommes vasectomis(~s pr(~sente des alt(~rations 
substantieUes qui augmentent avec le temps apr&s la chi- 
rurgie. 
L'auteur discute cette nouvelle indication de I'ICSI. 
Mots c l#s  : spermatozo~de testiculaire, azoospermie obstructi- 
ve, vasectomie, ADN nucleaire, ADN mitochondrial 
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